(Q64898735)

English

Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. (English)

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

epidermolysis bullosa acquisita

1 reference

based on heuristic

inferred from title

bullous pemphigoid

1 reference

based on heuristic

inferred from title

author name string

Claudia Giuli Santi

1

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Alexandre Carlos Gripp

2

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Ana Maria Roselino

3

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Danielle Santana Mello

4

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Juliana Olivieri Gordilho

5

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Paula Figueiredo de Marsillac

6

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Adriana Maria Porro

7

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

publication date

1 April 2019

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Anais Brasileiros de Dermatologia

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

94

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

2 Suppl 1

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

33-47

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe ocular involvement in a patient with epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita--a case with upper airways obstruction requiring tracheostomy and responding to cyclosporin

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgA-epidermolysis bullosa acquisita in a child resulting in blindness

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucosal morbidity in patients with epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular involvement in IgA-epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucous membrane pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification to the approach of the diagnosis of mucous membrane pemphigoid: A case report and literature review

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate therapy for ocular cicatricial pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical tacrolimus for oral cicatricial pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of mucous membrane pemphigoid with tacrolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of mucous membrane pemphigoid with infliximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurological disorders in patients with bullous pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management and prevention of recurrent herpes labialis in immunocompetent patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of herpes simplex infections: an evidence-based review

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment strategies in mucous membrane pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita: concise review and practical considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bullous pemphigoid and internal diseases - A case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful use of combined corticosteroids and rituximab in the treatment of recalcitrant epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Refractory epidermolysis bullosa acquisita: successful treatment with rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dapsone efficacy and adverse events in the management of mucous membrane pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premonitory epidermolysis bullosa acquisita mimicking eyelid dermatitis: successful treatment with rituximab and protein A immunoapheresis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunopathological evaluation of epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita: what's new?

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The management of mucous membrane pemphigoid and pemphigus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for bullous pemphigoid in the elderly: a prospective case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous immunoglobulin for treatment of severe acquired bullous epidermolysis refractory to conventional immunosuppressive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current concepts in the treatment of epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab for patients with refractory mucous membrane pemphigoid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral mucous membrane pemphigoid: complete response to topical tacrolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of mucous membrane pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita with moderately severe Dysphagia due to esophageal strictures

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucous membrane pemphigoid with severe esophageal stricture

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pemphigoid diseases: pathogenesis, diagnosis, and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic approaches to patients with mucous membrane pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Childhood epidermolysis bullosa acquisita: report of a Chinese case

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive therapy for autoimmune bullous diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of subepidermal immunobullous diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A consensus approach to wound care in epidermolysis bullosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of epidermolysis bullosa acquisita with rituximab therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of mucous membrane pemphigoid with mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of extracorporeal photochemotherapy in a patient with refractory epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pemphigoid diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunopathological characteristics of patients with bullous pemphigoid and neurological disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of bullous pemphigoid with low-dose oral cyclophosphamide: a case series of 20 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beware the blistering patient with dysphonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emerging treatments for pemphigoid diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucous membrane pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Off-label use of rituximab in dermatology: pemphigus treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines on the use of extracorporeal photopheresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory epidermolysis bullosa acquisita effectively treated with minocycline

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita: a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oesophageal involvement in epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis bullosa acquisita: current diagnosis and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of serological tests in diagnosis of autoimmune blistering diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The successful use of extracorporeal photopheresis in a 12-year-old patient with refractory epidermolysis bullosa acquisita.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bullous pemphigoid and neurological disease: statistics from a dermatology service

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracorporeal photopheresis for the treatment of autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral colchicine monotherapy for epidermolysis bullosa acquisita: Mechanism of action and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Childhood Epidermolysis Bullosa Acquisita: Confirmation of Diagnosis by Skin Deficient in Type VII Collagen, Enzyme-linked Immunosorbent Assay, and Immunoblotting

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features and diagnosis of epidermolysis bullosa acquisita

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin E Autoantibodies in Bullous Pemphigoid Detected by Immunoglobulin E Enzyme-Linked Immunosorbent Assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induced autoimmune bullous diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermolysis Bullosa Acquisita (Brunsting-Perry Pemphigoid Variant) Localized to the Face and Diagnosed With Antigen Identification Using Skin Deficient in Type VII Collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BPAG1, a distinctive role in skin and neurological diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurological and psychiatric associations in bullous pemphigoid - more than skin deep?

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association between bullous pemphigoid and neurological disorders: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of immunoglobulin E in bullous pemphigoid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoids: The mode of action in bullous pemphigoid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colchicine: an ancient drug with novel applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgE auto-reactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation of the epidermal expression of glucocorticoid receptor-beta as potential predictive marker of bullous pemphigoid outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab in pemphigus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-desmogleins autoantibodies detected by ELISA and blotting in bullous pemphigoid: what do they mean?

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eosinophils mediate tissue injury in autoimmune skin disease bullous pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between bullous pemphigoid and malignancy: A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-C*17, DQB1*03:01, DQA1*01:03 and DQA1*05:05 Alleles Associated to Bullous Pemphigoid in Brazilian Population

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating bullous pemphigoid 180 autoantibody can be detected in a wide spectrum of patients with other dermatologic conditions: A cross-sectional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bullous Pemphigoid Associated with Ischemic Cerebrovascular Accident and Dementia: Exclusive Blistering Lesions on the Upper Hemiparetic Limb

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological predictors shared by dementia and bullous pemphigoid patients point out a cross-antigenicity between BP180/BP230 brain and skin isoforms

1 reference

https://pubmed.ncbi.nlm.nih.gov/31166405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1590/ABD1806-4841.2019940207

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6544032

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64898735&oldid=1587673661"